PE20010931A1 - Oxazolidinonas que tienen la funcion de una sulfoximina - Google Patents

Oxazolidinonas que tienen la funcion de una sulfoximina

Info

Publication number
PE20010931A1
PE20010931A1 PE2000001363A PE0013632000A PE20010931A1 PE 20010931 A1 PE20010931 A1 PE 20010931A1 PE 2000001363 A PE2000001363 A PE 2000001363A PE 0013632000 A PE0013632000 A PE 0013632000A PE 20010931 A1 PE20010931 A1 PE 20010931A1
Authority
PE
Peru
Prior art keywords
alkyl
oxazolidinones
sulfoximine
function
thiazinan
Prior art date
Application number
PE2000001363A
Other languages
English (en)
Inventor
Hester
David L Alexander
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20010931A1 publication Critical patent/PE20010931A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A OXAZOLIDINONAS DE FORMULA I, DONDE A ES i, iii, iv, ENTRE OTROS; B ES a, b, c; W ES NHC(=X)R1, Y-HET; CUANDO A ES iv; W NO ES Y-HET; X ES O, S; CUANDO X ES O; B NO ES b; Y ES NH, O, S; Z ES S(=O)(=NR5); R1 ES ALQUILO C1-C4, CICLOALQUILO C3-C6(CH2)p OPCIONALMENTE SUSTITUIDO CON F, Cl, CN; R2 Y R3 SON H, F, Cl, ALQUILO; R4 ES H, CH3, F; R5 ES ALQUILO C1-C5, CO-ALQUILO C1-C4, ENTRE OTROS; p ES 0-2; n ES 2-3; j ES 1-5; SON COMPUESTOS PREFERIDOS N-({(5S)-3-[3-FLUORO-4-(1-IMINO-1-OXIDO-1 4,TIAZINAN-4-IL)FENIL]-2-OXO-1,3-OXAZOLIDIN-5-IL)METIL)ETANOTIOAMIDA, N-({(5S)-3-[3-FLUORO-4-(1-IMINO-1-OXIDO-1 4,4-TIAZINAN-4-IL)FENIL]-2-OXO-1,3-OXAZOLIDIN-5-IL)METIL)PROPANOTIOAMIDA, ENTRE OTROS. EL COMPUESTO I PUEDE SER UTIL COMO ANTIBIOTICO EN INFECCIONES OCULARES, CUTANEAS; UTILIZANDOSE DE 0,1 mg/Kg DE PESO/DIA A 100 mg/Kg DE PESO/DIA
PE2000001363A 1999-12-21 2000-12-19 Oxazolidinonas que tienen la funcion de una sulfoximina PE20010931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17191699P 1999-12-21 1999-12-21

Publications (1)

Publication Number Publication Date
PE20010931A1 true PE20010931A1 (es) 2001-08-29

Family

ID=22625632

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001363A PE20010931A1 (es) 1999-12-21 2000-12-19 Oxazolidinonas que tienen la funcion de una sulfoximina

Country Status (22)

Country Link
US (1) US20010046987A1 (es)
EP (1) EP1242417A1 (es)
JP (1) JP2003518117A (es)
KR (1) KR20020067557A (es)
CN (1) CN1221548C (es)
AR (1) AR029211A1 (es)
AU (1) AU782078B2 (es)
BR (1) BR0016605A (es)
CA (1) CA2389482A1 (es)
CO (1) CO5251427A1 (es)
CZ (1) CZ20022142A3 (es)
EA (1) EA005567B1 (es)
HU (1) HUP0203869A2 (es)
IL (1) IL150348A0 (es)
MX (1) MXPA02006233A (es)
NO (1) NO20022973L (es)
NZ (1) NZ519725A (es)
PE (1) PE20010931A1 (es)
PL (1) PL356478A1 (es)
SK (1) SK7572002A3 (es)
WO (1) WO2001046185A1 (es)
ZA (1) ZA200204166B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108794D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
ES2268011T3 (es) * 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0409217A (pt) 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
WO2006056877A2 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
ES2335307T3 (es) 2005-06-29 2010-03-24 PHARMACIA & UPJOHN COMPANY LLC Homomorfolin oxalidinonas como agentes antibacterianos.
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
EP1934208B1 (de) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
ATE233766T1 (de) * 1994-11-15 2003-03-15 Upjohn Co Antibakterielle bizyklische oxazin und thiazin- oxazolidinone
ATE207487T1 (de) * 1995-09-01 2001-11-15 Upjohn Co Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
ATE293609T1 (de) * 1997-05-30 2005-05-15 Upjohn Co Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität

Also Published As

Publication number Publication date
CA2389482A1 (en) 2001-06-28
MXPA02006233A (es) 2002-12-05
HUP0203869A2 (hu) 2003-07-28
WO2001046185A1 (en) 2001-06-28
JP2003518117A (ja) 2003-06-03
AU782078B2 (en) 2005-06-30
SK7572002A3 (en) 2002-12-03
NO20022973D0 (no) 2002-06-20
EA200200699A1 (ru) 2003-02-27
US20010046987A1 (en) 2001-11-29
CN1221548C (zh) 2005-10-05
ZA200204166B (en) 2003-10-29
CN1391572A (zh) 2003-01-15
BR0016605A (pt) 2003-02-25
AR029211A1 (es) 2003-06-18
NZ519725A (en) 2004-05-28
PL356478A1 (en) 2004-06-28
KR20020067557A (ko) 2002-08-22
EA005567B1 (ru) 2005-04-28
IL150348A0 (en) 2002-12-01
EP1242417A1 (en) 2002-09-25
CO5251427A1 (es) 2003-02-28
NO20022973L (no) 2002-08-20
AU2050201A (en) 2001-07-03
CZ20022142A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
PE20010931A1 (es) Oxazolidinonas que tienen la funcion de una sulfoximina
PE20011089A1 (es) Tioamidas de oxazolidinona con sustituyentes de piperazin-amida
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
PE20080952A1 (es) Amidas azociclicas fungicidas
PE20061130A1 (es) Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
PE20050874A1 (es) Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4
EA201070782A1 (ru) Производные оксадиазола, активные в отношении сфингозин-1-фосфата(sip)
PE20020585A1 (es) Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona
PE20020354A1 (es) Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
PE20070189A1 (es) COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
PE20110684A1 (es) Agonistas de los receptores de la melanocortina
CO5550397A2 (es) Orto-ciclopropil-tienil-carboxamidas con actividad fungicida
KR900018098A (ko) 피리돈 카르복실산과 항균제
NZ318515A (en) Cyclodepsipeptide PF1022 derivatives and compositions thereof
RU2010103102A (ru) Новые микробиоциды
PE20060366A1 (es) Derivados de aminopiridina como agonistas de dopamina
PE20080207A1 (es) DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5
PE20010851A1 (es) Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
PE20100052A1 (es) Derivados de 3-oxoisoindolin-1-carboxamida como inhibidores de los canales de sodio
PE20010166A1 (es) Nuevas oxazolidinonas biciclicas como agentes antibacterianos
PE20080270A1 (es) Compuestos de 1-(azolin-2-il)-amino-2-aril-1-heteroaril-etano sustituidos
PE20060619A1 (es) Derivados de oxazolidinona como antibacterianos
NO20071230L (no) Oksazolidinoner inneholdende oksindoler som antibakterielle midler
PE20070324A1 (es) Uso de moduladores no esteroides de receptores de progesterona

Legal Events

Date Code Title Description
FC Refusal